Synonyms: CCX 354 | CCX-354 | CCX-354-C
Compound class:
Synthetic organic
Comment: CCX354 is an orally active CCR1 antagonist that was originally developed by Chemocentryx for anti-inflammatory/immunomodulatory potential. The chemical structure is claimed as Example 16 in patent WO2008147815A1 [1]. The structure in the patent resolves to PubChem CID 25016615, which is a tautomeric representation of the claimed structure.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
1-[4-(4-chloro-3-methoxyphenyl)piperazin-1-yl]-2-(3-imidazol-2-ylidene-2H-pyrazolo[3,4-b]pyridin-1-yl)ethanone |
Synonyms ![]() |
CCX 354 | CCX-354 | CCX-354-C |
Database Links ![]() |
|
Specialist databases | |
GPCRdb Ligand | CCX354 |
Other databases | |
GtoPdb PubChem SID | 381118874 |
PubChem CID | 135565361 |
Search Google for chemical match using the InChIKey | WSVDLXWYJRCDBZ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | WSVDLXWYJRCDBZ |
UniChem Compound Search for chemical match using the InChIKey | WSVDLXWYJRCDBZ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WSVDLXWYJRCDBZ-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖